Taiwan FDA reviewing data on Novavax vaccine following EUA request

Taiwan's Food and Drug Administration (FDA) on Saturday said it was reviewing the technical data on the Novavax COVID-19 vaccine following the American drugmaker's recent request for emergency use authorization (EUA) in Taiwan.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)